15 Best Drug Stocks To Buy Now
The pharmaceutical industry is thriving globally, and it was given a healthy boost by the COVID-19 vaccine rollouts around the world.
Posts Tagged ‘NASDAQ:HZNP’
Billionaire John Paulson’s Latest Portfolio: Top 5 Stock Picks
In this article, we discuss the top 5 stock picks of billionaire John Paulson’s latest portfolio.
Top 5 Stock Picks of Samuel Isaly’s OrbiMed Advisors
In this article, we will discuss the top 5 stock picks of Samuel Isaly's OrbiMed Advisors.
Were Hedge Funds Right About Horizon Therapeutics Public Limited Company (HZNP)?
The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 867 13F filings that hedge funds and well-known value investors are required to file ...
5 Pharmaceutical Stocks to Buy Based on Billionaire Ken Griffin’s Portfolio
In this article, we discuss the top 5 pharmaceutical stocks to buy based on billionaire Ken Griffin’s portfolio.
Hedge Funds Are Piling Into Horizon Therapeutics (HZNP)
In this article we will analyze whether Horizon Therapeutics Public Limited Company (NASDAQ:HZNP) is a good investment right now by following the lead of some of the best investors...
Dov Gertzulin’s DG Capital Portfolio: Top 10 Stocks
In this article, we discuss the top 10 stocks in Dov Gertzulin's portfolio.
Were Hedge Funds Right About Horizon Therapeutics (HZNP)?
A whopping number of 13F filings filed with U.S.
10 Best Biotech Stocks to Buy According to Joseph Edelman’s Perceptive Advisors
In this article, we will discuss the 10 best biotech stocks to buy according to Joseph Edelman’s Perceptive Advisors.
Billionaire John Paulson’s 5 Biggest Stock Picks
In this article, we will discuss billionaire John Paulson's 5 biggest stock picks.
Do Hedge Funds Love Horizon Therapeutics Public Limited Company (HZNP)?
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first.
15 Best Pharmaceutical Stocks to Invest In
In this article, we discuss the 15 best pharmaceutical stocks to invest in.
5 Best Stocks to Buy According to John Paulson
In this article, we will discuss the 5 best stocks to buy according to John Paulson.
5 Best Pharmaceutical Stocks to Buy According to Billionaire Joseph Edelman
In this article, we discuss the 5 best pharmaceutical stocks to buy according to billionaire Joseph Edelman.
Here is What Hedge Funds Think About Horizon Therapeutics (HZNP)
In this article you are going to find out whether hedge funds think Horizon Therapeutics Public Limited Company (NASDAQ:HZNP) is a good investment right now.
Is Horizon Therapeutics Public Limited Company (HZNP) A Smart Long-Term Buy?
Carillon Tower Advisers, an investment management firm, published its “Carillon Eagle Mid Cap Growth Fund” first quarter 2021 investor letter – a copy of which can be downloaded...
Is Horizon Therapeutics (HZNP) A Good Stock to Short?
Carillon Tower Advisers, an investment management firm, published its fourth quarter 2020 “Carillon Eagle Small Cap Growth Fund” investor letter – a copy of which can be...
Is HZNP Stock A Buy or Sell?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Billionaire John Paulson’s Top 10 Stock Picks
In this article we presented billionaire John Paulson's top 10 stock picks.
Billionaire John Paulson’s Top 5 Stock Picks
In this article, we discuss billionaire John Paulson's top 5 stock picks.
Horizon Therapeutics (HZNP) Stock Hits New 52-Week High on Solid Q4 Results
Horizon Therapeutics PLC (NASDAQ:HZNP) was founded in 2008 with a handful of employees and extremely limited resources.
12 Best Large Biotech Stocks to Buy Now
Biotech companies are research science-driven companies focusing on novel drug development and clinical research with aims to treat diseases and medical conditions.
Is HZNP A Good Stock To Buy Now?
Is Horizon Therapeutics Public Limited Company (NASDAQ:HZNP) a good place to invest some of your money right now? We can gain invaluable insight to help us answer that question...
Were Hedge Funds Right About Crowding Into Horizon Therapeutics (HZNP)?
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (Recession is Imminent: We...
Hedge Funds Never Been This Bullish On Horizon Therapeutics (HZNP)
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Were Hedge Funds Right About Horizon Therapeutics Public Limited Company (HZNP) ?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Is Horizon Therapeutics (HZNP) A Good Stock To Buy?
We at Insider Monkey have gone over 821 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio...
Should You Buy Horizon Pharma Public Limited Company (HZNP)?
We hate to say this but, we told you so.
How Did Horizon Pharma Public Limited Company (HZNP) Compare Against Top Hedge Fund Stocks in 2019?
Last year's fourth quarter was a rough one for investors and many hedge funds, which were naturally unable to overcome the big dip in the broad market, as the S&P 500 fell by ...
Here is What Hedge Funds Think About Horizon Pharma Public Limited Company (HZNP)
Amid an overall bull market, many stocks that smart money investors were collectively bullish on surged through the end of November.
Did Hedge Funds Drop The Ball On Horizon Therapeutics Public Limited Company (HZNP) ?
At Insider Monkey, we pore over the filings of nearly 750 top investment firms every quarter, a process we have now completed for the latest reporting period.
Here’s What Hedge Funds Think About Horizon Therapeutics Public Limited Company (HZNP)
Does Horizon Therapeutics Public Limited Company (NASDAQ:HZNP) represent a good buying opportunity at the moment? Let’s quickly check the hedge fund interest towards the company...
Were Hedge Funds Right About Flocking Into Horizon Pharma plc (HZNP) ?
The fourth quarter was a rough one for most investors, as fears of a rising interest rate environment in the U.S, a trade war with China, and a more or less stagnant Europe, weighed...
Do Hedge Funds Love Horizon Pharma Public Limited Company (HZNP)?
A market correction in the fourth quarter, spurred by a number of global macroeconomic concerns and rising interest rates ended up having a negative impact on the markets and ...
Hedge Fund and Insider Trading News: Elliott Management, Third Point LLC, Square, Inc. (SQ), Brightsphere Investment Group PLC (BSIG), Zillow Group Inc (Z), and More
TOKYO (Reuters) - Alps Electric Co (6770.T) stock jumped 8 percent on Monday after the firm promised a share buyback of about 40 billion yen ($353 million) to win support for ...
35 Fresh Stories That You Should Read To Know How The Financial Markets Are Doing Today
"U.S. stocks slipped Monday, as declining prices for industrial metals weighed on materials shares.
Here’s Our Take On Horizon Pharma PLC (HZNP)’s Fall Out And Regeneron Pharmaceuticals Inc (REGN)’s EMA Hit
Thursday was a big day for two companies, in two very different ways, in the biotech space.
Horizon Pharma Inc (HZNP): Are Hedge Funds Right About This Stock?
Investing in hedge funds can bring large profits, but it’s not for everybody, since hedge funds are available only for high-net-worth individuals.
Horizon Pharma PLC (HZNP), Flamel Technologies S.A. (ADR) (FLML) & More: Why Should You Consider Following Broadfin Capital’s Investment Moves?
At Insider Monkey, we think that an investor can beat the market by imitating smart moves of big hedge funds into the top pick they are bullish on.
Horizon Pharma PLC (HZNP) Could Double Its Annual Sales Potential On This Near Term Catalyst
Horizon Pharma PLC (NASDAQ:HZNP) is up circa 15% on its Q3 2016 earnings report, and the company looks set to continue picking up strength even against a backdrop of politically...
This Healthcare Fund Just Had A Huge Q3: Here’s How
The mainstream media likes taking shots at hedge funds because they are easy targets.
Here’s Why Organovo Holdings Inc. (ONVO), Seagate Technology PLC (STX) & Three Other Stocks Are on Investors’ Radars Today
Among the stocks that are trending in Tuesday intraday session are Organovo Holdings Inc.
Here’s Why These Five Stocks Are Trending on Monday
Crude futures are up more than 1% today as investors look forward to this month's informal OPEC/Russia meeting in Algeria.
Depomed Inc (DEPO), Oracle Corporation (ORCL) & More: Why These Stocks Are Making Headlines
In this article, we analyze match the important events with the associated stocks, Depomed Inc (NASDAQ:DEPO), Horizon Pharma PLC (NASDAQ:HZNP), Oracle Corporation (NYSE:ORCL...
Raptor Pharmaceutical, Colgate-Palmolive Company & Others: Here’s Why These Stocks Are Trending Today
Although speculation continues over when the Federal Reserve will hike interest rates, investors seem to have brushed aside concerns over a rate hike for the immediate future.
Trading Week Kicks Off With A Bang for Wal-Mart and 4 Other Stocks
Disappointing trade figures out of China have investors on edge this morning as the trading week kicks off.
Here’s Why Traders Are Watching These Stocks Today
Investors are expecting a respite from the post-Brexit saga on Tuesday as the three major indexes in the US opened over 1% in the green as crude oil and pound are also showing...
Why These Five Stocks Are in Spotlight Today?
The US stock market is mixed on Monday intraday trading, with Dow Jones in the red, dragged by the declines registered by Caterpillar Inc.
Why These 5 Stocks are Losing Ground Today
The markets opened higher this morning amid hopes that a meeting of major oil producers scheduled for Sunday would result in a production freeze.
Kevin Kotler’s Healthcare Fund Broadfin Capital Just Had A Disastrous Q1
Though 2016 hasn't been great for the overall hedge fund industry so far, it is turning out to be an especially terrible year for biotech-focused hedge funds.
